ImmuCell Corp (ICCC)

4.50 +0.04  +0.84% NASDAQ Jun 3, 16:59 Delayed 2m USD

ImmuCell Revenue (TTM):

14.22M for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Revenue (TTM) Chart

Export Data
Save Image
Print Image

Historical Revenue (TTM) Data

View and export this data going back to 1989. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 14.22M
Dec. 31, 2019 13.72M
Sept. 30, 2019 13.03M
June 30, 2019 12.21M
March 31, 2019 12.52M
Dec. 31, 2018 10.99M
Sept. 30, 2018 11.18M
June 30, 2018 11.03M
March 31, 2018 9.768M
Dec. 31, 2017 10.43M
Sept. 30, 2017 9.512M
June 30, 2017 9.476M
March 31, 2017 10.10M
Dec. 31, 2016 9.544M
Sept. 30, 2016 10.02M
June 30, 2016 10.53M
March 31, 2016 10.11M
Dec. 31, 2015 10.23M
Sept. 30, 2015 9.740M
June 30, 2015 9.037M
March 31, 2015 8.617M
Dec. 31, 2014 7.597M
Sept. 30, 2014 6.951M
June 30, 2014 6.415M
March 31, 2014 6.242M
   
Dec. 31, 2013 6.007M
Sept. 30, 2013 5.869M
June 30, 2013 5.711M
March 31, 2013 5.520M
Dec. 31, 2012 5.390M
Sept. 30, 2012 5.274M
June 30, 2012 5.200M
March 31, 2012 5.273M
Dec. 31, 2011 5.111M
Sept. 30, 2011 4.930M
June 30, 2011 4.800M
March 31, 2011 4.630M
Dec. 31, 2010 4.386M
Sept. 30, 2010 4.294M
June 30, 2010 4.432M
March 31, 2010 4.356M
Dec. 31, 2009 4.506M
Sept. 30, 2009 4.722M
June 30, 2009 4.635M
March 31, 2009 4.460M
Dec. 31, 2008 4.634M
Sept. 30, 2008 4.889M
June 30, 2008 5.897M
March 31, 2008 6.029M
Dec. 31, 2007 6.069M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Benchmarks

Benchmarks
Emergent BioSolutions Inc 1.108B
Johnson & Johnson 82.73B
Fate Therapeutics Inc 10.56M

Revenue (TTM) Range, Past 5 Years

Minimum 9.037M Jun 2015
Maximum 14.22M Mar 2020
Average 10.87M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.